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The s-SHIP protein is a shorter isoform of the longer SHIP1 protein and lacks the N-terminal SH2 domain region contained in SHIP1.
s-SHIP is expressed in ES cells and in enriched bone marrow stem cells, and may be controlled by a promoter within intron 5 of the ship1
gene. We therefore examined the potential specificity of promoter activity in ES cells of an intron 5/intron 6 ship1 genomic segment and its
tissue specificity within transgenic mice expressing GFP from this promoter region. The results indicate that s-SHIP promoter activity is
specific for ES cells in vitro and for known and presumptive stem/progenitor cells throughout embryo development of the transgenic mice.
Specific GFP expression was observed in the blastocyst, primordial germ cells, thymus, arterioles, osteoblasts, and skin epidermis. The
epidermis/epithelium is the progenitor for hair follicles, mammary tissue, and prostate. Interestingly, each of these latter tissues acquired a
few GFP-positive cells in the course of their development from the epithelial layers, and these cells express marker proteins for stem/
progenitor cells. These results identify potential stem cell populations, mark these cells for analyses in normal and cancer development, and
implicate s-SHIP as an important protein in stem/progenitor cell function.
D 2005 Elsevier Inc. All rights reserved.Keywords: s-SHIP; Embryonic stem cells; Internal promoter; Transgenic mice; Inner cell mass (ICM); Primordial germ cells; Epidermis; Mammary buds; Hair
follicles; ProstateIntroduction
Stem cells are defined by their ability to self-replicate as
undifferentiated cells and to repopulate differentiated cell
tissues or compartments. Embryonic and adult stem cells
have become an increasingly important focus of research
because of their potential for tissue repair (Griffith and
Naughton, 2002; Smith, 2001), their role in cancer develop-
ment (Weissman et al., 2001), and/or the general curiosity0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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CA 94143-0446, USA.surrounding their pluripotent regenerative capabilities. In
mouse and man, stem cells have been identified for a
number of adult tissues such as those for blood cells
(Spangrude et al., 1988), mammary tissue (Smith and
Chepko, 2001), cornea (Grueterich et al., 2003), brain
(Gage, 2000; Sanai et al., 2004), epidermal (Tumbar et al.,
2004), mesenchymal (Pittenger et al., 1999), and the small
intestine and colon (Moser et al., 1992). Increasing evidence
also suggests that tissue stem cells could be the target for
oncogenic transformation in leukemia as well as breast and
brain cancer (Al-Hajj et al., 2003; Bonnet and Dick, 1997;
Morrison et al., 2002; Singh et al., 2003). Although adult
stem cells are now broadly investigated, much less is known
about embryonic stem/progenitor cells, other than primor-
dial germ cells and the inner cell mass from which ES cells
are derived.283 (2005) 503 – 521
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phosphatase, was first observed in blood cell signaling as
a tyrosine-phosphorylated protein in cells stimulated by M-
CSF, IL3, or several distinct cytokines or blood cell growth
factors (reviewed in Rohrschneider et al., 2000; Sly et al.,
2003). An N-terminal SH2 domain of p145 SHIP1 is
followed by a central inositol-polyphosphate 5Vphosphatase
enzymatic activity and an ¨350 amino acid C-terminal
region with numerous protein interaction motifs, which bind
PTB, SH2, and SH3 domains. The full-length SHIP1 protein
and spliced isoforms are expressed in hematopoietic cells
and testes, with much lower expression observed in a few
other adult tissues (Liu et al., 1998; reviewed in Rohrsch-
neider, 2003).
Functionally, both biochemical and genetic experiments
indicate that SHIP1 is a negative regulator of myeloid and
lymphoid cell proliferation, survival, and chemotaxis (see
Rohrschneider, 2003; Sly et al., 2003). The molecular
mechanisms for these effects require the attachment of the
SHIP1 SH2 domain to the cytoplasmic portions of trans-
membrane receptors containing appropriate tyrosine-phos-
phorylated interaction motifs (Sly et al., 2003). At the
membrane site, the SHIP1 inositol-5V phosphatase domain
converts the plasma membrane PI3K-produced product,
phosphatidylinositol(3,4,5)P3, to phosphatidylinositol(3,4)P2
effectively terminating proliferation signals. Therefore, the
SH2 domain of SHIP1 plays a critical role in initiating many
of these negative biological effects.
In addition to the p145 SHIP1 protein and its spliced
isoforms, the ship1 locus also expresses a smaller 104-kDa
protein lacking the N-terminal SH2 domain (Tu et al.,
2001). This product is called s-SHIP, with the prefix ‘‘s’’
signifying stem cell expression within ES cells and lineage-
depleted Sca1-positive stem cells of the bone marrow. This
protein was first described by Kavanaugh et al. (1996) and
called SIP-110 in the human; but details of its existence
were unclear until Tu et al. (2001) defined the complete
murine cDNA and demonstrated endogenous expression in
the two cell types described above. Structurally, s-SHIP
differs from SHIP1 only by the lack of nucleotide sequence
encoding 224 N-terminal amino acids, including the SH2
domain; but biochemically, s-SHIP also lacks tyrosine
phosphorylation and association with Shc (Kavanaugh et
al., 1996; Tu et al., 2001). Therefore, the lack of an SH2
domain in s-SHIP suggests that its interaction mechanism
with target proteins probably differs from that of SHIP1;
however, the biological functions of s-SHIP are not known.
Kavanaugh et al. (1996) suggested that s-SHIP was
produced by alternative splicing; however, Tu et al. (2001)
proposed, based on comparison of the murine genomic
ship1 sequence to the murine cDNA sequence, that a
distinct s-SHIP promoter might reside within intron 5 of the
ship1 gene. This was inferred from the observation that the
s-SHIP cDNA contained 44 intron 5 nucleotides at its 5V end
immediately before the identity with SHIP-encoding exons
6 through 27. These results are consistent with a functionalintron 5/6 promoter for s-SHIP. This possibility predicts that
s-SHIP transcription would begin within intron 5 (thus
lacking the SH2 domain of SHIP1) and continue with
properly spliced and assembled exons 6–27. Because s-
SHIP is detected in ES cells and in the enriched population
of mouse bone marrow stem cells (Tu et al., 2001), its
expression in the mouse might be particularly interesting.
To address questions about this potential s-SHIP pro-
moter and its tissue-specific expression profile in the mouse
embryo, we began functional analyses of the SHIP1 gene.
The first objective was to determine whether the intron 5/6
region of genomic ship1 contained stem cell-specific
promoter activity in cultured cell lines, and the second
goal, based on its reported expression in ES cells and bone
marrow stem cell populations, was to examine potential
stem/progenitor cell expression of the proposed s-SHIP
promoter in vivo. Our results indicate that the intron 5/6
promoter is indeed expressed in a subset of stem/progenitor
cells in mouse embryo development.Materials and methods
Immunoblotting analysis for SHIP proteins
The techniques for cell extraction, electrophoresis, and
immunoblotting have been described previously (Liu et al.,
2001). Equal amounts of protein extracts from each cell type
were loaded for gel electrophoresis. SHIP proteins were
detected using monoclonal antibody P2C6 at a 1:1000
dilution (Lucas and Rohrschneider, 1999). Extracting ES
cells with boiling lysis buffer did not change the size of the
s-SHIP protein, suggesting that proteolysis was not a factor.
Construction of the 11.5-kb and 6.2-kb GFP s-SHIP
promoter transgenes
The 11.5-kb GFP transgene was prepared from two
separate plasmids containing the two halves of the proposed
s-SHIP promoter region, plus an 833-bp sequence from a
lambda genomic clone, which was inserted between these
two halves. The genomic organization of SHIP1 is shown in
Wolf et al. (2000). The starting genomic clone contained a
4-kb region from the SacI site near the 3V end of the 7.6-kb
genomic clone in intron 6, extending through exon 8 and
into intron 8. This SacI–SacI fragment was cloned into the
SacI site of pBluescript SK (pBSK). The GFP gene from
pEGFP-1 (Invitrogen/Clontech) was excised with NcoI
(encompassing the ATG translation start site of GFP) and
SspI. This was ligated into the NcoI (the putative s-SHIP
translation start site in exon 7) and EcoRV sites of the
pBSK-4kb clone. Next, the 5V half of the genomic promoter
was added in the form of the SacI–SacI 7.6-kb genomic
sub-clone. This was inserted into the one remaining SacI
site at the 5V end of the intron 6-exon 7-GFP clone in pBSK.
This left a gap of 0.9 kb between the two SacI sites in intron
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larger BsiWI–EcoRI 2117 nt fragment, whose sequence
demonstrated the insertion of 833 nucleotides between two
SacI sites. Therefore, this BsiWI–EcoRI fragment was
inserted into the same unique sites of the transgene to
produce the finished 11.5-kb GFP transgene in pBSK.
The 6.2-kb GFP transgene was prepared from the 11.5-
kb GFP transgene prior to the insertion of the 833 bp at the
intron 6 SacI site. This, the 11.5-kb (D833) GFP con-
struction, was digested with FbaI and SwaI, removing 5.3
kb from the 5V end of intron 5. Re-ligation removed all but
19 intron 5 nt at the 5V end of the 11.5-kb GFP transgene.
Both 11.5-kb GFP and 6.2-kb GFP transgenes, in pBSK,
were cut from the plasmid with BssHII and Qiagen purified
from an agarose gel for introduction into the mouse genome.
Production of transgenic mice
Founder transgenic mice were prepared in our Transgenic
Mouse Facility by pronuclear injection of fertilized zygotes
from (C57Bl/6 female X CBA/J male) F1 mice. Mice were
screened by PCR using DNA obtained from tails of young
animals. The location of the primer set for PCR is shown in
Fig. 1: the upstream primer (a) is within intron 6 (Pro-up2,
5V-TACTCCTCAGCAAGAGTAGCTGG-3V), and the
downstream primer (b) within the GFP gene (GFP-dn1, 5V-
GCTGAACTTGTGGCCGTTTACGT-3V) produce a 632-bp
product. These primers were used for detection of both 6.2-
kb GFP and 11.5-kb GFP transgenic mice. Positive founder
mice were bred to C57Bl/6 mice and four lines (A, B, C, and
D) were obtained for the 11.5-kb GFP mice. Later analyses
demonstrated that founder line B was not positive for GFP
expression, even though the primer pair a and b gave a
positive 632-bp product. Therefore, line B is not included in
further analyses. The other lines were maintained by
breeding transgene-positive animals with wild-type C57Bl/
6 mice. For some experiments homozygous transgene-
positive offspring were generated from Tg-positive intra-
line breeding. Two founder animals were obtained for the
6.2-kb GFP transgene but one was lost.
The transgene copy number in each founder line (except
11.5-kb GFP, line B) was determined by semi-quantitative
RT-PCR of transgene expression relative to endogenous
Gab2 expression. Primers for detecting genomic gab2 are as
follows: E4F, 5V-CTTCTATAGCCTTCCCAAGCC-3V; E5R,
5V-CTCGTAGGTCTCACAGGAAG-3V.
All animal experiments followed IACUC approved
protocols.
Analysis of embryos
Pre-implantation embryos were harvested at 2.5 and 3.5
dpc from uterine horns of pregnant females (for details of
these methods, see Nagy et al., 2003). The morulae and
blastocysts were washed in RPMI 1640 medium (Gibco)
containing 10% fetal bovine serum, transferred to PBS(Ca2+ and Mg2+), and GFP-expression or phase images
photographed on a Nikon Eclipse TE200 inverted micro-
scope coupled to a Roper Scientific 1000  1000 pixel
digital camera. High-resolution z-sections of GFP expres-
sion within embryos were made with a Leica TCS SP
Confocal microscope. Individual embryo sections are
presented in Figs. 3Aa–c, and the entire z-stack from each
embryo was formatted as a Quick-time movie.
Several blastocysts were plated onto gelatin-coated tissue
culture wells in DME 10% fetal bovine serum, and
photographed 3 days later. During this period, blastocysts
hatched from the zona pellucida and attached to the culture
plate. The attached mass of trophectoderm cells with the
non-adherent ICM was photographed for GFP and phase
with a Nikon Eclipse TE200 microscope.
RT-PCR analysis of s-SHIP expression in blastocysts
mRNA was isolated from wild-type 3.5 dpc blastocysts,
FDC-P1 cells, and the D3 ES cells using a Dynabeads
mRNA DIRECT microkit (Dynal). Reverse transcription
used the Sensiscript kit (Qiagen), and the PCR cycling
conditions were as follows: 94-C 1 min [94-C 15 s, 68-C
2 min]30 cycles, 68-C 5 min, and a 4-C hold. Each
reaction used the equivalent of 1.5 ng mRNA, based on
the concentration before reverse transcription. Primer
pairs were as follows: HPRT-up1, 5V-CCTGCTGGATTA-
CATTAAAGCACTG-3V, HPRT-down1 5V-GTCAAG-
GGCATATCCAACAACAAAC-3 V; OCT4-Up1 5 V-
GGCGTTCTCTTTGGAAAGGTGTTC-3V, OCT4-Down1
5V-CTCGAACCACATCCTTCTCT-3V; SHIP1/s-SHIP pair
#3 (see Fig. 3B), SP2109FW, 5V-CAGCCCTGTCTTTG-
CCACGTTTG-3V, SP2637RV, 5V-TCCACTGGATT-
CATCCCGCTCTG-3V; SHIP1/s-SHIP pair #4 (see Fig.
3B), newfw, 5V-CTTCCTCTTGCAACAGAGAACCC-3V,
newrv, 5V-ACTCAACGTCCACTTTGAGATGC-3V.
Analysis of splicing of the 11.5-kb GFP expressed in
ES cells (Fig. 1D) used the following promers: up1-
5V-CCCAACTCCTCCCAAATCCCCTC-3V, up2-5V-CAG-
GATTCACCACTGGGGTGTGG-3V, up3-5V-CCCACTAG-
TTTGTTGAACTTTACC-3V, up4-5V-AGGTTGTTTGAC-
CAACAGCTTTCC-3V, dn5-5V-GGGCATCGACTTCA-
AGGAGGACGG-3V. The 11.5-kb GFP construct was trans-
fected into D3 ES cells using Lipofectamine 2000, and GFP-
positive colonies, visualized on an inverted Nikon fluores-
cence microscope, were picked. RNA was isolated (Gentra
RNA Purification kit) from non-transfected and 11.5-kb GFP
transfected ES cells. The DNA from the 11.5-kb GFP insert in
the pBSK plasmid served as unspliced control DNA. Under
the conditions of this experiment, RNA from the untrans-
fected ES cells gave no PCR products.
Analysis of embryo tissue sections by immunofluorescence
Embryos were harvested, washed, and fixed 2–4 h in 2%
paraformaldehyde in PBS, then washed in 30% sucrose in
Fig. 1. Structure of the 11.5-kb and 6.2-kb transgenic promoter-GFP for in vivo analysis. (A) The 11.5-kb GFP transgene contains the entire genomic ship1
segment from the SacI site near the 5V end of intron 5 through the putative translation start site at an ATG preceded by a suitable Kozak sequence within exon 7.
The translational start ATG for the enhanced GFP is fused, in frame, to the likely ATG translational start for s-SHIP. The 6.2-kb GFP transgene is identical to
that of the 11.5-kb GFP, except it contains only 0.96 kb upstream of exon 6 and lacks 833 bp within intron 6. Colored portions of DNA segment are part of the
transcript. (B) Transgenic founder lines were produced and transgenic-positive mice detected by PCR using the primer pair a and b (locations shown in panel
A). Four positive Tg 11.5-kb GFP founder lines were obtained (A–D), while only one survived for the Tg 6.2-kb GFP mice. The Tg 11.5-kb GFP founder line
B did not, however, express GFP (not shown). DNA from a non-transgenic C57Bl/6 mouse (WT) served as negative control, and the positive control used the
complete plasmid transgene. (C) Transgenic copy numbers were estimated by semi-quantitative PCR analysis relative to the endogenous diploid gab2 gene.
(D) Splicing and transcription start was analyzed by RT-PCR of RNA from ES cells expressing the 11.5-kb GFP transgene. Primer pairs shown in the diagram
would produce the expected unspliced or spliced RT-PCR products (lower left table). The gel figure (lower right) shows the PCR products obtained from the
unspliced transgene (left 4 lanes), or the RT-PCR product from ES cells transfected with the 11.5-kb GFP transgene.
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were frozen in O.C.T. on dry ice and stored at 80-C until
sectioned. Twenty-micrometer sections on Superfrost/Plus
(Fisherbrand) microscope glass slides were air-dried over-
night and stored, desiccated, at 20-C. Sections were
routinely stained with a rabbit anti-GFP antibody coupled to
Alexa 488 (Molecular Probes) to enhance the transgenic
GFP detection. For general screening, sections were also
stained with phalloidin coupled to Alexa 594 (molecular
Probes) for detecting morphology by filamentous actinstaining. Other antibodies used were specific for the
following: CD45-Cy-Chrome labeled, and Flk1 (VEGFR2)
phycoerythrin labeled (both from Pharmingen); Oct4,
mouse monoclonal (Santa Cruz Biotechnology); E-cadherin,
rat monoclonal (Zymed); and alpha smooth muscle actin,
mouse monoclonal (Sigma). The BM alkaline phosphatase
detection reagent was from Roche. The tissue sections were
blocked in 5% fetal bovine serum for 30 min, washed in
PBS, treated 10 min in 0.5% TX-100 in PBS then washed
again in PBS. The primary antibodies were applied and
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min. Sections were washed 3 times 10 min each in PBS and
secondary antibodies added and incubated as before. Final
washing was 3 times 15 min and sections were mounted in
ProLong (Molecular Probes). All secondary antibodies were
from Molecular probes and labeled with Alexa 594 or Alexa
633. Slides were viewed with a Leitz TCS SP Confocal
microscope or a Zeiss two-photon LSM.Results
We first used an in vitro strategy to test for ES cell-
specific promoter activity in the intron 5 region of genomic
ship1. A 7.6-kb intron-5-contaning segment of genomic
ship1, and sub-fragments, were found to have promoter
activity in ES cells but not in NIH3T3 cells (see
Supplementary Fig. S1). This promoter activity correlated
with s-SHIP protein expression in each cell type suggesting
that the intron 5 region contained the appropriate informa-
tion for cell-type-specific s-SHIP expression.
Transgene construction and production of transgenic mice
Based on the ES and NIH3T3 cell transfection experi-
ments, two additional promoter constructs, encompassing an
extended region downstream of the intron 5 genomic area,
were prepared for analysis of potential promoter/enhancer
activity in transgenic mice (Fig. 1A). The promoter in the
longer of the new constructions (the 11.5-kb GFP transgene)
contained almost the entire intron 5 from the 7.6-kb
genomic fragment, plus all of exon 6, intron 6, and a
portion of exon 7 ending at the theoretical ATG start site for
the s-SHIP protein translation (Kozak, 1987). Translation
from this ATG yields a predicted open reading frame of 928
amino acids and a theoretical protein of 104 kDa (Tu et al.,
2001), consistent with the size of s-SHIP shown in the
Supplementary Fig. S1B. The presumed s-SHIP transla-
tional start site was fused, in frame, to the ATG for the
enhanced green fluorescent protein (GFP). All of exon 6,
intron 6, and part of exon 7 were included to facilitate
expression and include potential regulatory elements
(Furger et al., 2002; Nott et al., 2004). This promoter will
be referred to as the intron 5/6 region in future descriptions.
A second, shorter, transgenic promoter (the 6.2-kb GFP
transgene) contained only 0.96 kb of intron 5 sequence
adjacent to exon 6, and also lacked 833 nucleotides between
two SacI sites within intron 6 (Fig. 1A). Thus, if either
genomic segment contained promoter activity in vivo,
predicted transcription should start within intron 5, intron
6 would be spliced out, and translation of GFP would begin
at the first ATG within an appropriate Kozak site.
The expression of GFP from both transgenic constructs
and the expected splicing of the Tg 11.5-kb GFP transgenic
construct were examined in ES cells and 293 cells. Both 6.2-
kb GFP and 11.5-kb GFP plasmids expressed fluorescentGFP in each cell type (not shown). Splicing of the expressed
mRNA was tested by RT-PCR of RNA from the ES cells
expressing the 11.5-kb GFP (Fig. 1D). A single downstream
primer in combination with each of 4 upstream primers
demonstrated that the transgene mRNA was consistent with
the expected transcription initiation site shown in Fig. 1A,
and proper splicing of exon 6 to exon 7.
Transgenic (Tg) mice were produced in the Hutchinson
Center Transgenic Mouse Facility and were screened for
each transgene by PCR. Breeding each founder to wild-type
C57Bl/6 mice yielded four lines containing the 11.5-kb GFP
transgene, and one line with the 6.2-kb GFP transgene (Fig.
1B). Of the four founder Tg 11.5-kb GFP mice, one was
negative for transgene expression (line B, not shown), while
three were positive. Copy numbers of genomic transgenes,
measured relative to the endogenous gab2 gene, are shown
in Fig. 1C. Results, presented below, are primarily from
founder line D, but all three GFP-positive lines have
exhibited the same in vivo expression patterns.
Analysis of transgene expression in the pre-implantation
mouse embryo
The Tg 11.5-kb GFP mice were examined to determine
transgene GFP expression in the embryo. Because transgene
expression was readily detectable in the initial ES cell
experiments (see Supplementary Fig. S1), we first looked
for GFP expression within the inner cell mass (ICM) of the
blastocyst, from which ES cells can be derived (Fig. 2).
Three-and-a-half days postcoitum (dpc) blastocysts derived
from a single cross between a homozygous Tg male and WT
female produced 9/9 GFP-positive embryos (Figs. 2a and b).
A heterozygous Tg male bred to a WT female produced both
positive and negative blastocysts (Figs. 2c and d). GFP-
positive morulae were obtained from similar crosses (Figs. 2g
and h); whereas, blastocysts or morulae from WT parents
were negative for GFP (Figs. 2i–l). These results indicate that
the transgene is active in the pre-implantation embryos.
Blastocysts are composed of 2–3 cell types depending
on their developmental stage. The outer trophectoderm layer
of cells surrounds the inner cell mass (ICM), destined to
become the embryo proper, and later stage blastocysts
contain endoderm cells separating the ICM from the
blastocoel cavity (Nagy et al., 2003). To examine these cell
types for GFP expression, 3.5-dpc blastocysts were allowed
to adhere to a culture dish by three days of growth in DME
10% FBS. During this time, the zona pellucida is shed, and
the outer trophectoderm cells of the blastocyst form an
adherent layer while the ICM remains as a cell mass, and
each is distinguishable morphologically. The results in Figs.
2e and f show that the ICM portion of the blastocyst retains
the GFP expression while the adherent trophectoderm cells
are largely negative for GFP expression.
A more detailed picture of GFP expression throughout
the intact early pre-implantation embryos was seen in
confocal z-sections of GFP within transgenic 2.5-dpc
Fig. 2. Blastocysts and morulae of Tg 11.5-kb GFP mice express the transgene. Pre-implantation embryos were harvested from 2.5-dpc and 3.5-dpc pregnant
transgenic (Tg) females and embryos flushed from the uterine horns. (a, b) Four blastocysts from a TgWT breeding viewed for transgene expression by GFP
fluorescence and embryo morphology by phase contrast microscopy. (c, d) Two blastocysts from a separate TgWT breeding showing one GFP-positive and
one GFP-negative blastocyst. (e, f) GFP-positive blastocysts were grown 3 days in culture, permitting growth and adhesion of the outer trophoblast layer of
cells with a clump of inner cell mass (ICM) atop the monolayer. GFP expression is retained in the ICM. (g, h) A single GFP-positive morula from a transgenic
embryo. (i, j) Two morulae from non-transgenic control mice lack GFP expression. (k, l) A single blastocyst from a non-transgenic control breeding pair does
not express GFP.
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to 32-cell morula were GFP positive (Fig. 3Aa). Transition
of the morula to the early blastocyst is marked by the
formation of the blastocoel cavity. A few cells of this early
blastocyst structure have begun to shut-off GFP expression,
and the extent of this GFP loss was more evident in the late
blastocyst (Figs. 3Ab and c). At this time, the outer
trophectoderm cells had noticeably lower GFP expression,
and the GFP-positive cells are confined to the ICM.
Endoderm cells were not readily apparent. Movies of z-
sections through each embryo shown in Figs. 3Aa–c are
available in Supplementary Fig. S2. Cells in the blastocyst
expressing the highest GFP levels correspond to the ICM,
which also express Oct4 (Pou5f1) in the nucleus (Figs.
3Ad–f). In all images, it is helpful to remember that the
half-life of the GFP fluorescence is greater than 24 h (Living
Color, Technical Brochure, ClonTech), and therefore GFP
protein and fluorescence will persist for several days after
transgene turn-off. Twenty-four hours separates the morula
from the blastocyst stages; therefore, transgene shut-off
early during this time would result in lower but not complete
lack of GFP fluorescence late in this time span. The
expression of transgenic GFP in the morula and ICM of
the blastocyst suggests some specificity in the promoter
region.
We tested for s-SHIP expression in blastocysts by RT-
PCR, compared to that of the universally expressed HPRT,
and the ES cell and ICM-specific Oct4 transcription factor
(Pesce et al., 1998) (Fig. 3B). FDC-P1 myeloid progenitor
cells express SHIP1 but not s-SHIP (Lucas and Rohrsch-
neider, 1999; Tu et al., 2001), while conversely, D3 ES cells
express only s-SHIP (Tu et al., 2001; Supplementary Fig.S1). These two cell types represented the positive and
negative controls. RNA from FDC-P1, D3 ES cells, and 3.5
dpc blastocysts were tested and each was positive for HPRT,
while mRNA from the blastocysts and ES cells, but not
from the FDC-P1 cells, was positive for Oct4, as expected.
s-SHIP was detected by ‘‘subtraction’’ using primers
common to both s-SHIP and SHIP1 (Fig. 3B, lane 3) vs.
primers detecting only the SHIP1 product (lane 4). The
products from these primers demonstrate the presence of
full-length SHIP1 only in the FDC-P1 cells, and s-SHIP in
both blastocysts and ES cells.
Analysis of transgene expression in the post-implantation
mouse embryo
Ongoing development of the blastocyst following
implantation of the embryo continues with the formation
of the epiblast (the embryo body) from cells comprising the
blastocyst ICM. Consistent with this derivation, the epiblast
in the Tg 11.5-kb GFP E6 embryo retained GFP expression
(Figs. 4A–C); however, within 24 h, epiblast GFP
expression was lost. E7–7.5 embryos exhibited individual
GFP-positive cells, or groups of cells, in the extraembryonic
membranes, often appearing to trail from the epiblast (Figs.
4D–I). By 8.5 dpc, GFP expression could no longer be seen
in the embryo body itself, but both the yolk sac and placenta
contained numerous GFP-positive cells (Figs. 4J–M). Serial
sections through the transgenic E8.5 decidua and growing
embryo have not detected specific GFP expression in any
tissue or cells of the embryo body. Specifically, GFP-
positive migrating primordial germ cells (PGCs) have not
been detected in the hindgut region of the E8.5 embryos (not
Fig. 3. (A) Confocal microscopy (z-sections) shows that transgene expression is uniform throughout the morula (a), exhibits some GFP shut-off in the early
blastocyst (b), and becomes confined to the ICM of the late stage blastocyst (c). The GFP+ blastocyst in panels d– f was stained with Oct4 antibody and serial
sections recorded for Oct4 (red) and GFP (green). Each image represents a composite of 112 individual sections corresponding to the blastocyst half containing
the ICM. (B) Expression of s-SHIP in blastocysts is detected by RT-PCR. RNA was isolated from 3.5-dpc blastocysts, FDC-P1 myeloid progenitor cells
(known to express only SHIP1), and D3 ES cells (known to express only s-SHIP) by the DynaBead method. RT-PCR was performed using control primers to
hypoxanthine phosphoribosyl transferase (HPRT) and the transcription factor Oct4. Each HPRT lane is positive in the three cell types, while the Oct4 is
positive, as expected, only in the blastocysts and ES cells. Lanes 3 and 4 show s-SHIP detection by the primer pairs, whose locations relative to SHIP1 and s-
SHIP cDNA are shown below the PCR panels. The arrowed brackets indicate positions of forward and reverse primers, respectively, and each bracket is named
for the corresponding lane using that primer pair. The results show that SHIP1 is expressed in the FDC-P1 cells because RT-PCR of RNA from these cells is
positive in both lanes 3 and 4; whereas s-SHIP (but not SHIP1) is present in the blastocysts and ES cells because lane 3 is positive and lane 4 negative using
RNA from these cells. The red at the 5V end of s-SHIP represents the SSR sequence not found in SHIP1 cDNA.
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regions, however, the ectoplacental plate (also called
chorionic plate) contained patches of GFP-positive cells,
which did not express VEGFR2 (compare Figs. 4K and L).
The blood islands and endoderm cell layer of the yolk sac
contained individual or small groups of GFP-positive cells
(Figs. 4J and N–P). Occasional intense GFP+ round cells
within the primitive erythrocyte-filled blood islands were
observed, and groups of GFP+ cells adjacent to blood
islands were also seen (Supplementary Fig. S3). GFP+ cells
of the peripheral ectoplacental plate sometimes appeared
contiguous with GFP+ endodermal cells of the yolk sac (Fig.
S3). Maternal placental contributions did not account for the
yolk sac nor ectoplacental plate expression profiles, because
the same GFP expression patterns were observed inembryos from Tg males mated to WT females (not shown).
This GFP expression pattern in the yolk sac is similar to that
reported using an enhancer derived from the Scl(Tal1) stem
cell protein (Sa´nchez et al., 1999), suggesting that these
GFP+ cells may be related to hemangioblasts. However, we
have not detected Scl(Tal1) expression in the E8.5 GFP+
extraembryonic membrane cells (unpublished observation).
In contrast to the lack of GFP expression within the 8.5-
dpc embryo proper, whole-mount observations of 11.5 dpc
Tg 11.5-kb GFP embryos showed dramatic GFP expression
in the caudal region of the embryos (Figs. 5A and B) and a
distinct pattern of GFP expression on, and around, each
hindlimb/forelimb pair (Figs. 5C–E). This complex pattern
represented multiple distinct expression sites. At this age of
development, the strongest and most broadly observed site
Fig. 4. Expression of GFP in the E6–E8.5 transgenic mouse embryos. (A–C) GFP, phase, and merged images, respectively, of the whole-mount transgenic E6
embryo. (D) Whole-mount GFP expression in the E7 embryo. (E) The E7.5 embryo exhibits GFP in the extraembryonic membranes and placenta. (F)
Brightfield of the same E7.5 embryo shown in panel E. (G, H) GFP and phase images of an E7.5 embryo lacking placenta. (I) Frozen section of an E7 embryo
showing GFP expression in the placenta and extraembryonic membranes. Red is from a phalloidin-Alexa594 staining of filamentous actin. (K–M) Frozen
section of an E8.5 embryo showing images of GFP, VEGFR2 (Flk1), and a merged overlay, respectively. An enlargement of the placental area from panel K is
shown in panel J. (N) Frozen oblique section through the placenta and yolk sac of an E8.5 embryo. GFP staining is green; anti-CD45 reactivity is blue; and
phalloidin-Alexa594 labeling is red. (O) Yolk sac of E8.5 embryo showing one blood island attached to endoderm. GFP+ cells are present in both blood island
and endoderm. (P) Yolk sac from a different E8.5 embryo showing GFP+ blood island cells.
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developing skin. This was seen in whole mounts but
demonstrated best in frozen sections of E11.5 transgenic
embryos (Figs. 5I, J, K, and M–P). The E11.5 transgenic
embryos exhibited extensive GFP expression in the body
and limbs, but such expression was not seen in the head
region at this embryonic stage (data not shown). A second
epidermis-related GFP expression site was the apical
ectodermal ridge (AER) of each developing limb (see
Supplementary Fig. S4), and a third distinct pattern was
the mammary buds. These latter structures form by
invaginations of the skin epidermis and were observed as
five GFP-positive spots between each forelimb/hindlimb
pair, corresponding to the bilateral three thoracic and two
inguinal developing mammary glands. These were seen inwhole-mount embryos (Fig. 5F) or underneath the dissected
epidermis (Fig. 5G).
An additional prominent GFP expression site in 11.5-dpc
Tg 11.5-kb GFP embryos was the genital ridge where PGCs
were accumulating (Figs. 5I–K). The dissected aorta-
gonad-mesonephros (AGM) region from an E13.5 embryo
demonstrated the localization of the GFP+ cells within the
gonads (Fig. 5H). The PGCs co-express the nuclear
transcription factor Oct4 within the GFP+ cells, identifying
these GFP+ cells as PGCs (Fig. 5L). Panels I–K and M–P
of Fig. 5 show the dorsal aorta and liver, respectively; both
tissues in which GFP expression has not been detected
above background (personal observations). The dorsal aorta
is also present in the dissected AGM (Fig. 5H) between the
two gonads, but specific GFP expression was not observable
Fig. 5. In contrast to the E8.5 embryo, GFP expression in the E11.5–E13.5 transgenic embryo body is strong and detected at multiple sites. Whole-mount
E11.5 embryos viewed under a stereo fluorescence microscope exhibit GFP expression in the caudal region (A and C, GFP; B and D, respective brightfield). A
closer look at the GFP expression in forelimb/hindlimb region (E) and specifically in an embryo with well-developed mammary buds (F). The skin from the
mammary bud region of an E11.5 line C embryo was dissected and viewed from the underside with a Nikon fluorescence microscope (G). The AGM region of
an E13.5 embryo was dissected and viewed with a Nikon fluorescence microscope. Only the gonads express GFP+ cells. A single frozen section of an E11.5
embryo was stained with anti-GFP-Alexa488 (green), anti-CD45 for blood cells (blue), and phalloidin-Alexa594 for filamentous actin (red). GFP alone is
shown in panel I, phalloidin alone is shown in panel J, and an overlay of all three in panel K. An enlarged view of primordial germ cells in the genital ridge is
shown in panel L, stained for GFP (green) and Oct4 (red). Another frozen section from an E11.5 embryo was stained for GFP, actin, and blood cells, and
imaged for GFP alone (M), GFP plus blood cells (N), actin only (O), and all three merger in an overlay (P). Abbreviations: sk, skin; gr, genital ridge; da, dorsal
aorta; nt, neural tube; l, liver; fl, forelimb.
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aorta suggests a lack of any relationship to definitive
hematopoiesis, reportedly arising from this region (Dzierzak
et al., 1998).
Primordial germ cells
GFP expression in the PGCs of the Tg 11.5-kb GFP
embryo was examined in more detail during E9.5–E18.5
stages of embryonic development. Using Oct4 as a marker
for PGCs, we followed the temporal co-expression of GFP
and Oct4 from embryonic days 9.5 to 18.5. Consistent with
earlier results, GFP was not expressed in the earliest E9.5PGCs migrating along the hindgut, although Oct4 was
present in their nuclei (Figs. 6Aa–c). At E11.5, PGCs
expressing both GFP and nuclear Oct4 are visible in the
genital ridges (Figs. 6Ad–f). Together with the earlier
analyses of the E8.5 embryos, these results suggest that GFP
is not expressed in the early migrating PGCs of the E8.5–
E9.5 embryo.
The result in Figs. 6Ba–c shows GFP expression in PGCs
from an E13.5 embryo ovary. Many of the GFP+ PGCs cells
at this stage were in cell division (not shown). Primitive
seminiferous tubules are distinguishable in the E15.5 testes
(Figs. 6Bd–f), populated with GFP+ PGCs and developing
spermatogenic cells (Kaufman, 2001). The brightest GFP+
Fig. 6. Confocal microscopy analyses of GFP transgene expression in the gonads. (A) Frozen sections were prepared from E9.5 and E11.5 embryos and stained
with anti-GFP-Alexa488 and anti-Oct4 antibodies (plus secondary Alexa594 antibody). GFP is expressed only in the genital ridge region of E11.5 embryos. (B)
Frozen sections form E13.5, E15.5, and E18.5 embryos were analyzed for GFP expression in primordial germ cells of the gonads, counterstained with
phalloidin-Alexa594. Sex bias in GFP expression of the primordial germ cells has not been observed.
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type A spermatogonia undergoing cell division (Kaufman,
2001). The seminiferous tubules of the E18.5 embryo were,
likewise, filled with GFP+ spermatogenic cells (Figs. 6Bg–i).
Sertoli cells attached to the basement membrane of the
seminiferous tubule were GFP negative. Although both
ovaries and testes are not shown, germ cells in each were
positive for GFP in the E13.5–E18.5 stages of embryo
development. However, quite surprisingly, neither ovaries
nor testes of adults expressed GFP in any stage of germ cellformation (see Supplementary Fig. S5). These observations
indicate that the expression of the 11.5-kb GFP transgene is
positively regulated during the E11.5–E18.5 developmental
stages, but negatively regulated in the adult.
The 11.5-kb GFP transgene expression in additional tissues
from E15.5 to E18.5 embryos
Following E11.5 in the Tg 11.5-kb GFP embryo, new
GFP+ structures are observed. Specifically, the developing
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cornea is formed from an outer epithelial layer and an inner
cell layer derived from neural crest cells. Only the outer
epithelial layer was GFP+. The retina, derived from neuro-
epithelium, did not express GFP, while the lens, although an
invagination of the epidermis, was likewise GFP negative.
E15.5 embryos began to exhibit GFP expression in cells
surrounding blood vessels, and this expression became more
noticeable at E18.5 (Fig. 7C). The expression was restricted
to smaller vessels and not expressed in larger arteries (e.g.,
aorta) or veins. The vessel-associated GFP was expressed in
cells wrapping around the circumference of the vessels. This
characteristic suggests the GFP+ cells are smooth muscle
cells, and this notion was supported by the observation thatFig. 7. Additional distinct sites of GFP expression in the E15.5–E18.5 embryos
embryo (GFP and filamentous actin stain). (B) The developing vomeronasal organ
express GFP in the E18.5 embryo (GFP and actin stain). (D–F) The GFP+ blood
arteries/arterioles. Note that not all alpha smooth muscle actin+ vessels are GFP+.
individual GFP+ cells of the thymus attach via E-cadherin to the stroma of the thym
cells. Arrows indicate attachment points between the GFP+ cell and the matrix. (L
trabecular bone (femur shown here) and also express GFP (L). Similar GFP+ cel
Alkaline phosphatase activity (blue) identifies osteoblasts in the developing bone o
population (GFP and DAPI stained in N). Note that the strong alkaline phosphatalpha-smooth muscle actin co-localized with the GFP+
vessel cells (Figs. 7D–F). GFP was not detectable in all
vascular smooth muscle cells (vSMCs) (not shown) and was
also not detected in cardiac or skeletal smooth muscle cells.
This indicates a highly specific regulation of the 11.5-kb
GFP transgene only in a population of the smooth muscle
cells associated with small blood vessels.
A few scattered cells in the E15.5 thymus were also
positive for GFP (Fig. 7G). Morphologically, these cells did
not appear to be blood derived, but rather adhered to the
thymus stroma via E-cadherin (Figs. 7H–K), suggesting an
epithelial nature.
The paired vomeronasal (Jacobson’s) organ in the nasal
septum also expressed GFP (Fig. 7B). Jacobson’s organ is. (A) Frozen section exhibiting GFP expression in the cornea of the E15.5
expresses GFP in the E15.5 embryo (GFP and actin stain). (C) Blood vessels
vessels also stain for alpha smooth muscle actin indicating the vessels are
(G) A few cells of the E15.5 thymus are GFP+ (GFP and actin stain). The
us (GFP and E-cadherin stain) (H–K). Enlarged views of two GFP+ thymus
, M) Small irregularly shaped cells of the E18.5 embryo associate with the
ls are not observed in the E18.5 non-transgenic mouse femur (M). (N, O)
f an E18.5 embryo (O), and the GFP expression overlaps with the osteoblast
ase reaction product quenches GFP emission fluorescence in panel N.
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potential connection between transgene expression and
epidermal-derived tissues.
The E17.5–E18.5 transgenic embryos exhibited GFP
expression in cells associated with the forming bone matrix
(Figs. 7L and M). These small irregularly shaped GFP+ cells
are attached to the newly formed bone and are most likely
the osteoblasts in the process of converting extracellular
matrix material to bone (Komori et al., 1997; Long et al.,
2004). This was confirmed by demonstrating the colocali-
zation of alkaline phosphatase and GFP in these cells (Figs.
7N and O). Trabecular bone also exhibited alkaline
phosphatase-positive/GFP+ osteoblasts (Supplementary
Fig. S6).
Transgene expression in embryonic epidermis, tissues
derived from epidermis, and other epithelial cells
Embryonic skin is a major stem/progenitor cell popula-
tion essential for formation of several appendages and
tissues, such as, hair follicles, sweat glands, mammary
tissue, and (more indirectly) prostate. Therefore, these
epidermal-derived tissues were examined for GFP expres-
sion in our Tg 11.5-kb GFP embryonic mice.
Hair follicle formation initiates around E13.5 by recip-
rocal inductive signals between skin epidermis and under-
lying mesenchyme (Miller, 2002). The resultant hair follicle
placodes exhibit a localized epidermal thickening in a
geometrically ordered array due to inhibitory signaling
between placodes (Andl et al., 2002). The results in Fig. 8A
demonstrate that E13.5 transgenic embryos exhibit a geo-
metric array of GFP+ speckles in the skin, suggesting GFP
expression in the hair follicle placodes. Frozen sections of
skin at this stage revealed GFP+ epidermal thickening
indicating placode formation (Fig. 8B). Growth and
extension of the placodes into the mesenchyme produces
the hair follicle sheath with a distal bulb (Alanso and Fuchs,
2003). Early stages of hair follicle formation show the
incorporation of GFP+ skin epidermal cells into the follicleFig. 8. GFP expression in embryonic epithelial cells and the tissues derived from t
stereo fluorescence image of a transgenic E13.5 embryo showing the GFP+ hair pl
as a green shadow in the caudal peritoneum. (B) Frozen section of hair follicle plac
actin (red). (C, D) Stages in hair follicle development and GFP expression in frozen
actin as in panel B. A row of GFP+ epidermal cells appear to grow into the follicl
follicle (C). The few GFP+ cells remain as a cluster as the follicle grows further i
outer layer is convoluted and strongly autofluorescent (green). (E) In the more dev
papilla end of the follicle and both the interfollicular epidermal layer and follicle s
for GFP (F), and nuclei with To-Pro3 (G). An overlay of both images is shown in
the follicle, and a noticeable lack of strong GFP expression is evident at the oppo
DP) does not express GFP. (I, J) Mammary bud formation follows a protocol sim
visible both as a thickening of the epidermis and as buds forming into the derm
mammary bud (MB) growing into the dermis. The mammary bud forms a more bu
grown considerably into the dermis and exhibit ductal formation in cross section (L
forms at the initial bud site and the nipple sheath (NS) is GFP+. The growing mamm
the prostatic region of the urethra exhibits strong GFP expression where prostate
become the vas deferens and the ‘‘nose’’, the medial lobe of the prostate. The ‘‘mo
corners of the urethra.extending about one cell diameter into the mesenchyme
(Fig. 8C). The dermal component of the follicle (the dermal
papilla) is GFP and clearly visible in Fig. 8C adjacent to
the GFP+ cells. As the follicle extends further, the GFP+
cells remain as a small cluster, perhaps maintaining their
epidermal cell niche. During further growth of the hair
follicle, the GFP+ cell cluster remains intact at the distal
bulb end of the growing follicle, and the follicle retains the
E-cadherin expression, as does the epidermis from which it
is derived (Fig. 8E). Frequently, the base of each growing
hair follicle (anchored in the epidermis) lacks significant
GFP expression (Figs. 8F–H), and the GFP+ cluster resides
at the distal bulb end of the follicle.
Mammary bud formation also occurs from skin epider-
mis by epidermis–mesenchyme induction but differs in the
time of initial formation, the size of placodes, and
morphology of the developing tissue. The mammary buds
were visible in whole-mount immunofluorescence of the
E11.5 transgenic embryos (Figs. 5F and G), and frozen
sections taken at the same stage show GFP+ mammary
placodes (Fig. 8I). These placodes round up and extend into
the mesenchyme forming the buds (Figs. 8J and K), which
subsequently form larger bulbous structures as they grow.
The results in Fig. 8K also demonstrate the size of a hair
follicle relative to a mammary bud at this stage. This
growing embryonic mammary tissue exhibits a few GFP+
cells at the outside periphery of the tissue (Figs. 8L and M).
The expanding mammary tissue remains attached to the
epidermis and the nipple sheath forms around this attach-
ment site (Fig. 8M).
A third tissue derived from epithelium is the prostate
organ. However, unlike hair follicles and mammary buds,
prostate is formed from urogenital sinus epithelium by
poorly understood signals at the base of the bladder in the
E17.5 male mouse. Frozen sections of the prostatic region of
the E18.5 Tg 11.5-kb GFP male mouse demonstrated
specific GFP expression in regions destined to become
lateral lobes of the prostate (Fig. 8N). Serial sections
through this region showed GFP expression only in thehis source—hair follicles, mammary glands, and prostate. (A) Whole-mount
acodes in the epidermis. The primordial germ cells in the gonads are visible
odes in an E13.5 transgenic embryo stained for GFP (green) and filamentous
sections from an E18.5 transgenic embryo stained for GFP and filamentous
e, and the dermal papilla (DP) is visible as the red ‘‘cap’’ of the developing
nto the dermis (D). At E18.5 the epidermis is stratified and the keratinized
eloped hair follicle the GFP+ cell cluster (green) has remained at the dermal
tain for E-cadherin (red). (F–H) Frozen section of an E18.5 embryo stained
panel H. The GFP+ cell cluster is asymmetrically situated in the bulb-end of
site epidermal end of the follicle. The dermal component of the follicle (the
ilar to hair follicle formation. At E11.5, GFP+ mammary bud placodes are
is. (K) An E15.5 embryo section showing both a hair follicle (HF) and a
lbous structure compared to the hair follicle. (L, M) At E18.5 the buds have
). Only the peripheral cells of the developing tissue express GFP. The nipple
ary primary duct (PD) extends from this site (M). (N) In the E18.5 embryo,
tissue is developing from the uroepithelium. In panel N, the ‘‘eyes’’ will
uth’’ is formed by the urethra, and prostate tissue develops from the lateral
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expression. Overall, these results indicate that epidermal/
epithelial tissue constitutes a major target for expression of
the 11.5-kb GFP transgene, and tissues derived from
epithelium appear to obtain (and maintain) stem cells from
these sources.
The results in Fig. 9 demonstrate that embryonic
epidermal tissues express Trp63 in the GFP+ cells of theTg 11.5-kb GFP mouse. At E13.5 the skin epidermis is
about 1-cell thick and both Trp63 and GFP expression is
confined to this undifferentiated epidermal layer (Figs. 9A–
D). Mammary buds at E13.5 also co-express GFP and Trp63
throughout the bud (Figs. 9E–H), as do hair follicles and
sweat glands in the E18.5 embryo skin (Figs. 9I–L). Trp63,
a p53 family member, is expressed specifically in epithelial
cells of both embryo and adult and is required for epithelial
Fig. 9. Epidermal cells express both GFP and Trp63 in transgenic embryos. (A–D) E13.5 skin epidermis expresses p63 in the nucleus of the GFP+ epidermal
cells. (E–H) A mammary bud from an E13.5 transgenic embryo. (I–L) A transverse section through a single sweat gland (SG) and oblique sections through
two hair follicles (HF). Both sweat glands and hair follicles are derived from epidermis and each expresses p63 in their GFP+ cells.
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1999), or perhaps commitment to an epithelial stratification
program (Koster et al., 2004).
Expression of GFP from the shorter 6.2-kb GFP transgene
in the mouse embryo
The 6.2-kb GFP transgene mice were produced for the
purpose of obtaining information about expression capa-
bility of shorter promoter segments compared to the 11.5-kb
GFP transgene mice. In pre-implantation embryos the
shorter transgene was strongly expressed throughout the
blastocyst and no delineation was apparent between the
ICM and trophectoderm cells in the intact blastocyst, or in
blastocysts allowed to adhere to tissue culture plastic (Figs.
10A–C, compare to Figs. 2e and f). This lack of ICM
specificity could be due to the higher copy number in the
single Tg 6.2-kb GFP founder, and/or to the higher
expression of the transgene. Regardless, later developmental
stages exhibited highly tissue-specific expression patterns,
and dramatic differences in the 6.2-kb GFP transgene
expression compared to the 11.5-kb GFP transgene were
observed. The qualitative differences were not yet apparent
in E8.5 embryos; however, at this stage the Tg 6.2-kb GFP
E8.5 embryos no longer expressed GFP ubiquitously but
only cells of the extraembryonic membranes were GFP+
(Figs. 10D–F). This expression was similar to that observed
with the same stage Tg 11.5-kb GFP embryos; however,
yolk sac expression was not observed in the Tg 6.2-kb GFPmice (not shown). Surprisingly, unlike the Tg 11.5-kb GFP
mice, the E11.5–E13.5 Tg 6.2-kb GFP embryos were
devoid of significant GFP expression. Thus, at these
developmental stages, two of the most prominent GFP
expression sites in the Tg 11.5-kb GFP embryos (i.e., skin
epidermis and PGCs in the genital ridge and gonads) were
completely absent in the Tg 6.2-kb GFP embryos (data not
shown).
At still later developmental times, E18.5, two of the GFP
expression sites seen in the Tg 11.5-kb GFP embryos were
observed in the Tg 6.2-kb GFP embryos. These sites were
the blood vessels (Figs. 10G–I) and the osteoblast cells
attached to the forming bone matrix (Figs. 10J–L). GFP
was expressed in the smaller blood vessels, but not all small
vessels expressed GFP.
Therefore, the expression of the 6.2-kb GFP transgene
within the embryo was limited to fewer tissues than
observed with the Tg 11.5-kb GFP mice and represented a
subset of expression sites seen within the Tg 11.5-kb GFP
mice at the same developmental stage. These results suggest
that the promoter sequence remaining within the 6.2-kb
GFP transgene contains the information (enhancers) for
tissue-specific expression of GFP in cells of the extraem-
bryonic membranes at E8.5 and in the smooth muscle cells
surrounding blood vessels, and osteoblast in late stage
embryos. Conversely, the genetic sequences present in the
11.5-kb GFP transgene, but absent from the 6.2-kb GFP
transgene, contain important instructions (perhaps in con-
junction with the shorter promoter sequence) for tissue-
Fig. 10. Expression of GFP in transgenic embryos produced from the shorter 6.2-kb GFP transgene. (A–C) GFP expression (A) and phase (B) images of an
E3.5 blastocyst. Panel C shows the GFP expression in the blastocyst after adhesion to tissue culture plastic. (D–F) Frozen section through the placenta/
extraembryonic region of an E8.5 embryo showing GFP expression (D), embryo structure stained for filamentous actin (E), and an overlay of both images (F).
(G–I) Alpha smooth muscle cells of the E18.5 embryo stain strongly for GFP (G) but not all such vessels are as GFP+ (H, I). (J–L) GFP expression near an
ossification center of an E18.5 phalange (J), and filamentous actin stain (K) of the same section. The overlay of the two images shows bone-associated
osteoblasts (L). The keratin layer of the epidermis exhibits autofluorescence in panels J and K.
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tissues derived from skin epidermis.Discussion
The results presented here demonstrate that the intron 5/6
region of the ship1 gene contains the promoter/enhancer for
tissue-specific expression in primitive embryonic cell
populations. GFP expression by the 11.5-kb GFP construct
was first observed in cultured ES cells, then in all
blastomeres of the morula, and in the ICM of the blastocyst
from Tg 11.5-kb GFP mice. Thus, the initial embryo
expression occurred uniformly in the totipotent cells of the
pre-implantation embryo (morula). The blastocyst had
already restricted GFP expression to the ICM, and following
implantation, the initially GFP+ epiblast also lost GFPexpression; however, at E7.5 a few cells in the extraem-
bryonic membranes and placenta were GFP+. Observations
at different times indicated these cells originated near the
epiblast, and probably gave rise to the few GFP+ yolk sac
cells seen in the blood islands beginning at E8.5. The
embryo proper lacked GFP expression from E7.5 to about
E10.5, but strong GFP expression was observable around
E11.5 in skin epidermis, mammary buds, developing
gonads, limb AER region, and a few days later, the
developing hair follicles. From E15.5 to E18.5 the AER
GFP label (and structure) vanished, but skin epidermal cells
retained GFP expression. During this time, however, GFP+
cells of the skin appendages were retained in a small cluster
(hair follicles) or a few peripheral epithelial cells (mammary
tissue). Also, vSMCs, osteoblasts of developing bone, the
vomeronasal organ, prostate, and a few cells of the thymus
were GFP+ at E15.5–E18.5. A figure illustrating the
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GFP embryo is presented in the Supplementary Fig. S7.
Several significant points can be made about the
embryonic expression pattern of the 11.5-kb GFP transgene.
First, a strong preference exists for stem/progenitor cells (ES
cells, morula, ICM, primordial germ cells, epidermis), but
also for several cell types of yet undefined character and
potential (extraembryonic cells, yolk sac cells, thymus,
vomeronasal cells, vSMCs, osteoblasts). Second, no clear
continuum of GFP-expressing cells is observed throughout
embryo development; rather, it is likely that transgene
expression is turned on and off at various stages and
locations during development. Third, as observed in the Tg
11.5-kb GFP vs. the Tg 6.2-kb GFP mice, distinct portions
of the intron5/6 promoter/enhancer are essential for tissue-
specific expression. Finally, transgene GFP expression was
never observed in more mature cells of either embryonic or
adult tissues (not shown), and many of the GFP+ stem/
progenitor cells in the embryo are also retained in the adult
tissues (manuscript in preparation). These results indicate
that s-SHIP expression is spatially and temporally regulated
throughout development (see Supplementary Table 1).
Although several tissues expressed the GFP transgene,
most tissues and organs did not, and these include tissues
with defined or postulated stem/progenitor cell activity, such
as muscle, pancreas, small intestine, and colon (Charge and
Rudnicki, 2003; Marshak et al., 2001; for a contrasting view
Dor et al., 2004). Also negative for GFP expression were the
E11.5 dorsal aorta and E13.5 fetal liver sites, respectively,
where definitive hematopoiesis is proposed to occur, and
where primitive hematopoietic stem cells home and develop
(Dzierzak et al., 1998). This indicates that the 11.5-kb GFP
transgenic GFP promoter/enhancer is highly tissue specific
in its activity, and certainly not active in all proposed stem/
progenitor cells of the embryo.
Regarding hematopoiesis, although GFP expression has
not been observed at the proposed sites of definitive
hematopoiesis in either the aorta–gonad–mesonephros
region or the endothelial wall of the E9.5–E11.5 dorsal
aorta, strong GFP expression was observed in cells
migrating to the extraembryonic membranes at E8.5 and
in the ectoplacental (or chorionic) plate (Figs. 4D, E, I, J–
M). Recent reappraisal of definitive hematopoiesis has
suggested that the placental labyrinth region contains the
majority of blood forming cells, which expand dramatically
between E11 and E12 (Gekas et al., 2005; Ottersbach and
Dzierzak, 2005). The labyrinth region is embryo derived, as
is the ectoplacental plate, which is anchored to the labyrinth
and forms attachments to both the embryo yolk sac and
umbilical artery and vein. Therefore, the GFP+ cells in the
ectoplacental plate could be progenitors for the attached
structures and/or blood cells transported to the embryo;
however, further characterization of this population is
required.
In all the GFP+ cells and tissues of the transgenic mice it
is important to know whether the endogenous s-SHIPprotein is also expressed. Immunoblotting and RT-PCR
analyses have detected s-SHIP expression in ES cells and in
the blastocyst, both strongly GFP+ in the transgenic mice.
However, it has been more difficult to detect s-SHIP
expression in other tissues and we are continuing to refine
our techniques for this analysis.
An embryonic epithelial cell connection
The 11.5-kb GFP transgene containing the s-SHIP
promoter/enhancer has demonstrated a preference, not only
for expression in stem/progenitor cells, but also for those
cells of epithelial lineages. The embryonic skin epidermis is
strongly GFP+ from E11.5 until birth and gives rise,
sequentially, to the limb bud AER and mammary buds at
E11.5, hair follicles (also vibrissae, and tactile or sinus hair
follicles) and sweat glands (E13.5–E18.5), and the cornea
(E15.5) (see Fig. S7). Additionally, the prostate (E17–
E18.5) and vomeronasal organ (E15.5) are derived from
epithelial cells of urinary tract and neural origin, respec-
tively. Embryonic skin epidermis, initially only a single cell
layer thick, stratifies in the course of development and these
epidermal layers continue to express GFP in the embryo;
however, the basal layer retains the strongest expression.
The epidermal basal cell layer contributes directly to
mammary bud and hair follicle formation, and in the case
of hair follicles, a few GFP+ basal cells appear to
incorporate directly into the follicle, adjacent to the dermal
papillae, and remain at the distal bulb end of the follicle as it
extends into the mesenchyme. At E18.5, this cluster of
GFP+ cells resides in a circumscribed region of the
developing hair follicle (the adult follicle bulge?) in contact
with the dermal papilla. This organization resembles that
seen in the telogen phase of the adult hair regrowth cycle
(Alanso and Fuchs, 2003), a phase primed for neonatal hair
growth. The location of these GFP+ cells is analogous to
that described for adult hair follicle stem cells defined by
long-term retention of BrdU label (Tumbar et al., 2004).
GFP expression in the mammary bud of 11.5-kb GFP
transgenic mice is initially similar to hair follicle develop-
ment, but the growing bud does not retain a cluster of GFP+
cells. Rather, the growing bud exhibits weak GFP expres-
sion and the proximal epidermal end retains strong GFP
expression, perhaps in preparation for the nipple develop-
ment. E18.5 mammary tissue contains GFP in a few cells at
the periphery of the growing mammary gland. This GFP
expression profile is similar to mammary stem cells
identified by Sca1 expression within luminal epithelial cells
of adult mouse mammary gland (Welm et al., 2002). We
have also observed a small number of GFP+ cells within the
adult mammary gland (in preparation). Thus, like hair
follicles, embryonic mammary tissue derives potential stem
cells from the mid-gestational epidermis.
The observation of a few GFP+ cells within the
developing thymus of Tg 11.5-kb GFP mice was initially
puzzling; however, the identification of these cells as E-
L.R. Rohrschneider et al. / Developmental Biology 283 (2005) 503–521 519cadherin-expressing epithelial cells suggested they might fit
into the common epithelial/stem cell theme. The thymus
epithelium at E15.5 is derived from pharyngeal endoderm
(Gordon et al., 2004) and contributes to a heterogeneous
network of epithelial cells in the cortical and medullary
thymus. Although the function of the epithelial–thymocyte
interaction in adult thymus is important for generation of
functional T cells, such fetal interactions are necessary for
epithelial cell development and creation of the thymic
microenvironment (Manley, 2000). Cortical and medullary
epithelia share a common progenitor (Klug et al., 1998), and
a common stem/progenitor cell for all subpopulations of
thymic epithelial cells has been postulated (Farr et al.,
2002). The expression of GFP in a few epithelial cells of the
Tg 11.5-kb GFP E15.5 thymus, prior to cortical-medullary
formation, marks these cells as potential candidates for such
a stem/progenitor population.
Primordial germ cells and GFP expression
The expression of the GFP in PGCs represents a
straightforward relationship between a stem cell population
and GFP expression, and closer inspection reveals interest-
ing behavior. For example, PGCs migrating from their
origin in the posterior primitive streak, along the hindgut to
the genital ridge, express Oct4 but not GFP until approach-
ing their destination. E-cadherin is also not expressed in
migrating PGCs but expression is turned on near the genital
ridge (Bendel-Stenzel et al., 2000). E-cadherin is expressed
strongly in PGCs within the gonads and appears at points of
PGC-PGC contact. Therefore, an E-cadherin/h-catenin
signal is a candidate for switching on GFP expression
following migration of the PGCs. As PGCs assemble in the
gonadal blastema a second event in GFP expression is
observed. At E11.5, PGCs labeled for Oct4 and GFP do not
express both labels uniformly, and many Oct4+, GFP cells
are seen. It is not clear how GFP expression is being
regulated, but transcriptional regulation and asymmetric cell
division may be worthwhile examining. Later in develop-
ment, GFP expression remains strong in the germ cells until
sometime after birth when GFP expression disappears
completely from all stages of adult oocyte and sperm
development (Fig. S5).
Non-epithelial expression sites
Two cell types, which expressed GFP in the transgenic
mice but which are unrelated to epithelial cells, are
osteoblasts and the vSMCs. In both cases the origin of these
cells is from the mesodermal compartment. Each cell type,
however, is of considerable interest because of existing
connections with stem cells. The osteoblasts in adult bone
marrow have been described as important niche cells for
regulating hematopoietic stem cells (HSC) through asym-
metric cell division and thus commitment toward blood cell
lineages (Calvi et al., 2003; Zhang et al., 2003). This isanalogous to the Cap cells or Hub cells in the Drosophila
testis and ovary, respectively, which likewise control the
germ-line stem cell production of mature spermatocytes or
oocytes (Kai and Spradling, 2003; Lu et al., 2001; Song and
Xie, 2002, 2003; Yamashita et al., 2003). The notion that
osteoblasts are niche cells is supported by earlier experiments
showing that conditional ablation of osteoblasts leads to loss
of hematopoietic cells (Visnjic et al., 2001). Also, osteoblast
cell lines can expand HSC (Taichman et al., 2000), and
osteoblasts co-transplanted with HSC increase the engraft-
ment rate (El-Badri et al., 1998). It is not clear whether
osteoblasts in the fetal bone provide similar functions, and the
reason for GFP expression in these cells is not understood.
vSMCs exhibit a physiological life beyond what might
be imagined from their principal function in mature animals
of regulating blood pressure and blood flow distribution
(reviewed in Owens et al., 2004). Contractile vSMCs within
the embryo and adult retain a remarkable plasticity,
dramatized by their ability to proliferate, migrate, and
change phenotype in response to vascular injury, then upon
resolution of the injury, return to their previous phenotype,
and again regulate blood flow and pressure. The vSMCs to
which these cells can change are quite varied and trans-
differentiation depends upon the environmental cues
encountered (e.g., matrix proteins, growth factors) (Frid et
al., 1994; Hao et al., 2002). Many of these properties
contribute to possible roles of vSMCs in human diseases
such as atherosclerosis, systemic hypertension, and indi-
rectly venous malformations, a disease primarily affecting
endothelial cells and altering communication with vSMCs
(Vikkula et al., 1996). The stem/progenitor cell properties of
vSMCs could be related to their GFP expression in the Tg
11.5-kb GFP mice; however, further analyses are required to
understand any potential relationship.
The overall results of s-SHIP promoter analyses in both ES
cells in vitro, and the 11.5-kb GFP mice, indicate that the
intron 5/6 region of the ship1 gene is an internal promoter
potentially regulating s-SHIP expression. Internal promoters
are unusual but present in both viral genomes and several
genes of embryonic and adult signaling proteins. Such
promoters may have arisen by acquisition of individual
promoters, or mutations within introns, or by recombination
events resulting in addition of new coding sequences to
existing proteins while retaining the existing promoter as an
intron. A particularly relevant example is the p53, p63, and
p73 family of transcription factors. Like SHIP1/s-SHIP, both
p63 and p73 not only have internal promoters producing
isoforms lacking segments of the N-terminal trans-activation
domains (McKeon, 2004; Yang et al., 2002); but also, the
p63/ mice exhibit phenotypic abnormalities affecting
those epithelial tissues, which express the GFP in our Tg
11.5-kb GFP mice. GFP and p63 are expressed in many of
the same epithelial cells, and the ship1 intron 5 promoter/
enhancer contains a motif for binding this family of
transcription factors. Potential relationships between these
proteins are under investigation.
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